IDiyas

For the Inventor, By the Inventor

Fujisawa, Japan

Fumio Kai

USPTO Granted Patents = 10

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Fujisawa, JA (1976)
  • Fujisawa, JP (1978 - 1988)

Company Filing History:

goldMedal10 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents

Years Active: 1976-1988

Loading Chart...
10 patents (USPTO):
1. 4758557 - Cephalosporin derivatives and bactericides containing the same (1988-07-19),
2. 4647572 - Iodoallyl and iodopropargyl substituted tetrazoles and anti-microbial (1987-03-03),
3. 4563472 - Iodoallyl and iodopropargyl substituted tetrazoles and anti-microbial (1986-01-07),
4. 4560750 - Cephem compounds and process for preparing the same (1985-12-24),
5. 4485235 - Process for preparing 7-.alpha.-methoxycephem compounds (1984-11-27),
6. 4258184 - Cephalosporin derivatives (1981-03-24),
7. 4256744 - Agricultural and horticultural pesticides (1981-03-17),
8. 4141790 - Process for the preparation of 7-amino-cephem compounds using mold fungi (1979-02-27),
9. 4113944 - Cephalosporin-type antibiotics and process for producing the same (1978-09-12),
10. 3932668 - Composition for treating swine scour (1976-01-13),

Title: Fumio Kai: Innovator in Pharmaceutical Chemistry

Introduction

Fumio Kai is a prominent inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with bactericidal properties. With a total of 10 patents to his name, his work has had a substantial impact on medical and agricultural applications.

Latest Patents

Fumio Kai's latest patents include innovative cephalosporin derivatives and bactericides. These compounds exhibit a broad bactericidal spectrum against various pathogenic bacteria, including Pseudomonas aeruginosa. They are designed to serve as effective bactericidal remedies for both human and animal diseases. Additionally, he has developed triiodoallyl- and iodopropargyl-substituted tetrazole compounds. These compounds are prepared through specific chemical reactions and are useful in antibacterial and antifungal compositions across medicinal, agricultural, and industrial fields.

Career Highlights

Fumio Kai is associated with Meiji Seika Kaisha, Ltd., where he has been instrumental in advancing pharmaceutical research. His innovative work has led to the creation of compounds that address critical health challenges. His expertise in chemical synthesis and compound development has positioned him as a key figure in his field.

Collaborations

Fumio Kai has collaborated with notable colleagues, including Shigeo Seki and Taro Niida. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Fumio Kai's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and agricultural applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…